Pvg Asset Management Corp Amgen Inc Transaction History

Pvg Asset Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $730,479 - $856,286	-4,382 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $792,572 - $893,402	4,382 New	4,382 $832,000
Q4 2018 Feb 15, 2019	SELL	$178.4 - $208.25 $465,980 - $543,949	-2,612 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$185.29 - $208.89 $1.37 Million - $1.55 Million	-7,410 Reduced 73.94%	2,612 $541,000
Q2 2018 Aug 15, 2018	BUY	$166.05 - $186.51 $1.66 Million - $1.87 Million	10,022 New	10,022 $1.85 Million

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Pvg Asset Management Corp with notifications on news.